1. Pharmacokinetic Drug‐Drug Interaction Study of Omecamtiv Mecarbil With Omeprazole, a Proton Pump Inhibitor, in Healthy Subjects. Issue 1 (16th July 2021) Authors: Trivedi, Ashit; Sohn, Winnie; Jafarinasabian, Pegah; Zhang, Hanze; Terminello, Bianca; Flach, Stephen; Abbasi, Siddique; Dutta, Sandeep; Lee, Edward Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 1(2022) Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Omecamtiv mecarbil does not prolong QTc intervals at therapeutic concentrations. Issue 1 (16th July 2021) Authors: Trivedi, Ashit; Hsu, Cheng‐Pang; Jafarinasabian, Pegah; Terminello, Bianca; Zhang, Hanze; Flach, Stephen; Israel, Samuel; Brooks, Ashley; Xue, Hongqi; Darpo, Borje; Abbasi, Siddique; Dutta, Sandeep; Lee, Edward Other Names: Magavern Emma guestEditor.; Piasecki Jan guestEditor.; Cremers Serge guestEditor.; Cohen Adam guestEditor. Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 1(2022) Page Start: 187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Switchability and minimal effect of food on pharmacokinetics of modified release tablet strengths of omecamtiv mecarbil, a cardiac myosin activator. (18th June 2021) Authors: Trivedi, Ashit; Oberoi, Rajneet K.; Mackowski, Mia; Jafarinasabian, Pegah; Zhang, Hanze; Flach, Stephen; Simiens, Mary Ann; Terminello, Bianca; Abbasi, Siddique; Dutta, Sandeep; Lee, Edward Journal: Biopharmaceutics & drug disposition Issue: Volume 42:Number 7(2021) Page Start: 319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗